Twist Bioscience Corporation

BIT:1TWST Stock Report

Market Cap: €6.8b

Twist Bioscience Management

Management criteria checks 2/4

Twist Bioscience's CEO is Emily Leproust, appointed in Apr 2013, has a tenure of 13.42 years. total yearly compensation is $13.78M, comprised of 5.2% salary and 94.8% bonuses, including company stock and options. directly owns 0.66% of the company’s shares, worth €44.41M. The average tenure of the management team and the board of directors is 3.3 years and 8.9 years respectively.

Key information

Emily Leproust

Chief executive officer

US$13.8m

Total compensation

CEO salary percentage5.22%
CEO tenure13.4yrs
CEO ownership0.7%
Management average tenure3.3yrs
Board average tenure8.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Emily Leproust's remuneration changed compared to Twist Bioscience's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2026n/an/a

-US$137m

Mar 31 2026n/an/a

-US$81m

Dec 31 2025n/an/a

-US$77m

Sep 30 2025US$14mUS$720k

-US$78m

Jun 30 2025n/an/a

-US$85m

Mar 31 2025n/an/a

-US$191m

Dec 31 2024n/an/a

-US$197m

Sep 30 2024US$8mUS$685k

-US$209m

Jun 30 2024n/an/a

-US$220m

Mar 31 2024n/an/a

-US$192m

Dec 31 2023n/an/a

-US$206m

Sep 30 2023US$8mUS$685k

-US$205m

Jun 30 2023n/an/a

-US$209m

Mar 31 2023n/an/a

-US$213m

Dec 31 2022n/an/a

-US$214m

Sep 30 2022US$6mUS$665k

-US$218m

Jun 30 2022n/an/a

-US$208m

Mar 31 2022n/an/a

-US$188m

Dec 31 2021n/an/a

-US$165m

Sep 30 2021US$1mUS$590k

-US$152m

Jun 30 2021n/an/a

-US$135m

Mar 31 2021n/an/a

-US$123m

Dec 31 2020n/an/a

-US$117m

Sep 30 2020US$7mUS$519k

-US$140m

Jun 30 2020n/an/a

-US$147m

Mar 31 2020n/an/a

-US$147m

Dec 31 2019n/an/a

-US$141m

Sep 30 2019US$8mUS$477k

-US$108m

Compensation vs Market: Emily's total compensation ($USD13.78M) is above average for companies of similar size in the Italian market ($USD2.97M).

Compensation vs Earnings: Emily's compensation has increased whilst the company is unprofitable.

CEO

Emily Leproust (53 yo)

13.4yrs
Tenure
US$13,781,570
Compensation

Dr. Emily Marine Leproust, Ph D., is Director of GeneDx, Inc. from July 2021. Dr. Leproust was Director of Atlas Data Storage, Inc. since May 2025.Dr. Leproust serves as Independent Director at CM Life Sc...

Leadership Team

NamePositionTenureCompensationOwnership
Emily Leproust
Co-Founder13.4yrsUS$13.78m0.66%
€ 44.4m
Patrick Finn
President & COO3.9yrsUS$8.02m0.073%
€ 4.9m
Adam Laponis
Chief Financial Officer2.7yrsUS$4.22m0.038%
€ 2.6m
Dennis Cho
Chief Legal Officer & Corporate Secretary5yrsUS$3.62m0.014%
€ 926.6k
Paula Green
Senior Vice President of Human Resources10.5yrsUS$3.35m0.19%
€ 12.7m
Robert Werner
VP & Chief Accounting Officer3.3yrsno data0.021%
€ 1.4m
Siyuan Chen
Chief Technology Officer5.6yrsno datano data
Michael Fero
Chief Information Officer1.9yrsno datano data
Colby Souders
Chief Scientific Officerno datano datano data
Nicole Moreno
Senior Vice President of Sales & Support1.8yrsno datano data
Jimmy Jin
Senior Vice President of Product & Marketingless than a yearno datano data
Angela Bitting
Chief Corporate Responsibility Officer & Senior VP of Corporate Affairs1.6yrsno datano data
3.3yrs
Average Tenure
53.5yo
Average Age

Experienced Management: 1TWST's management team is considered experienced (3.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Emily Leproust
Co-Founder13.4yrsUS$13.78m0.66%
€ 44.4m
Keith Crandell
Independent Director12.9yrsUS$299.97k0.17%
€ 11.2m
Robert Chess
Lead Independent Director12.2yrsUS$337.47k0.10%
€ 6.9m
Nelson Chan
Independent Director7.3yrsUS$312.47k0.045%
€ 3.0m
Robert Ragusa
Independent Director9.8yrsUS$304.97k0.038%
€ 2.6m
Jan Johannessen
Independent Director7.9yrsUS$313.72k0.020%
€ 1.4m
Katryn Blake
Independent Director1.1yrsUS$404.00k0.027%
€ 1.9m
Melissa Starovasnik
Independent Director5.1yrsUS$304.97k0.027%
€ 1.9m
8.9yrs
Average Tenure
65.5yo
Average Age

Experienced Board: 1TWST's board of directors are considered experienced (8.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/10 22:05
End of Day Share Price 2026/09/10 00:00
Earnings2026/06/30
Annual Earnings2025/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Twist Bioscience Corporation is covered by 17 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert BambergerBaird
Catherine Ramsey SchulteBaird
Luke SergottBarclays